Free Trial

Healthcare Stocks List

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$56.24
-5.6%
$56.79
$37.55
$91.10
$5.06B1.781.12 million shs4.02 million shs
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$105.72
-0.8%
$105.04
$89.67
$121.64
$185.39B0.745.22 million shs10.33 million shs
CVS Health Co. stock logo
CVS
CVS Health
$61.37
+0.6%
$60.47
$52.77
$83.25
$76.58B0.5311.14 million shs20.87 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$148.75
+0.7%
$148.05
$143.13
$175.97
$355.66B0.536.69 million shs15.18 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$883.88
-0.2%
$798.59
$434.34
$905.45
$842.05B0.362.34 million shs3.45 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$130.72
+0.8%
$128.85
$99.14
$133.10
$328.43B0.397.46 million shs17.18 million shs
Novartis AG stock logo
NVS
Novartis
$105.22
-0.5%
$100.88
$92.19
$108.78
$216.13B0.581.23 million shs1.30 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$27.74
$27.67
$25.20
$38.99
$157.19B0.730.49 million shs52.56 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$9.71
+0.6%
$11.89
$9.59
$30.41
$1.64B0.993.98 million shs11.42 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$482.59
-0.4%
$497.01
$436.38
$554.70
$445.94B0.583.53 million shs6.78 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
0.00%-11.52%+0.92%-21.46%-1.28%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.02%+1.97%+1.42%-4.39%-0.50%
CVS Health Co. stock logo
CVS
CVS Health
-0.11%+1.91%+10.28%-21.80%-10.76%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.01%+2.21%-0.63%-4.17%-9.23%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-0.07%+0.62%+9.37%+14.70%+95.12%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
+0.12%+0.96%-0.29%+5.55%+17.60%
Novartis AG stock logo
NVS
Novartis
+0.06%-0.47%+4.09%+9.34%+4.27%
Pfizer Inc. stock logo
PFE
Pfizer
-0.02%+0.76%-3.34%+1.39%-28.69%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.00%-2.90%-15.16%-35.27%-60.35%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
-0.12%-2.92%-6.63%-1.53%+1.22%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
1.9771 of 5 stars
4.20.00.00.01.92.50.6
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9812 of 5 stars
3.44.04.24.52.32.52.5
CVS Health Co. stock logo
CVS
CVS Health
4.9785 of 5 stars
3.33.03.33.91.53.33.8
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.7707 of 5 stars
3.23.04.23.92.01.71.9
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4.2747 of 5 stars
2.43.00.84.03.12.51.9
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4.4385 of 5 stars
2.33.03.34.13.91.71.3
Novartis AG stock logo
NVS
Novartis
3.135 of 5 stars
2.15.02.50.03.10.02.5
Pfizer Inc. stock logo
PFE
Pfizer
4.846 of 5 stars
3.23.04.24.82.01.71.9
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.8016 of 5 stars
4.21.00.00.02.22.51.3
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4.983 of 5 stars
3.55.04.24.02.41.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2.35
Hold$75.7134.63% Upside
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.70
Moderate Buy$120.6414.11% Upside
CVS Health Co. stock logo
CVS
CVS Health
2.57
Moderate Buy$75.0522.29% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.38
Hold$174.0717.02% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.84
Moderate Buy$803.50-9.09% Downside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.69
Moderate Buy$133.001.74% Upside
Novartis AG stock logo
NVS
Novartis
2.25
Hold$116.6710.88% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.40
Hold$35.8629.26% Upside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.33
Hold$18.2287.63% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
2.95
Moderate Buy$579.7420.13% Upside

Current Analyst Ratings

Latest Healthcare Stocks Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/20/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00 ➝ $215.00
6/18/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$155.00 ➝ $155.00
6/17/2024
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$105.00 ➝ $105.00
6/17/2024
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$88.00 ➝ $88.00
6/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$175.00 ➝ $175.00
6/17/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$885.00 ➝ $885.00
6/17/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00 ➝ $45.00
6/12/2024
CVS Health Co. stock logo
CVS
CVS Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$58.00 ➝ $58.00
6/12/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$591.00 ➝ $591.00
6/11/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$885.00 ➝ $885.00
6/7/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$925.00 ➝ $957.00
(Data available from 6/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$371.21M12.87N/AN/A$23.70 per share2.37
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.59$6.31 per share16.75$22.36 per share4.73
CVS Health Co. stock logo
CVS
CVS Health
$357.78B0.22$12.23 per share5.02$59.55 per share1.03
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.20$13.76 per share10.81$28.57 per share5.21
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$34.12B24.62$7.61 per share116.17$11.44 per share77.26
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$60.12B5.51$3.07 per share42.62$14.85 per share8.80
Novartis AG stock logo
NVS
Novartis
$45.44B4.73$11.05 per share9.52$22.87 per share4.60
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.69$2.98 per share9.32$15.81 per share1.75
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.60B0.63$0.82 per share11.89$14.05 per share0.69
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$371.62B1.20$29.66 per share16.27$102.08 per share4.73

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
-$153.61M-$2.72N/AN/AN/AN/A-11.56%-9.70%8/5/2024 (Estimated)
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2132.9320.652.5613.96%20.18%10.60%7/18/2024 (Estimated)
CVS Health Co. stock logo
CVS
CVS Health
$8.34B$5.6910.797.910.582.03%13.53%4.03%8/7/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.2713.632.4645.26%36.70%15.07%7/17/2024 (Confirmed)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$5.24B$6.79130.1745.841.9317.08%56.98%10.94%8/13/2024 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$365M$0.90145.2413.182.503.76%14.05%5.24%7/30/2024 (Confirmed)
Novartis AG stock logo
NVS
Novartis
$14.85B$7.4114.2012.861.6231.33%32.15%13.59%7/18/2024 (Confirmed)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B-$0.06N/A10.091.09-0.56%8.64%3.70%8/6/2024 (Estimated)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$220.37M-$1.41N/AN/AN/A-8.90%-10.13%-5.37%7/23/2024 (Estimated)
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$22.38B$16.3629.5015.611.414.05%26.50%8.60%7/16/2024 (Confirmed)

Latest Healthcare Stocks Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2024N/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.14N/A-$2.14N/AN/AN/A  
7/18/2024N/A
Novartis AG stock logo
NVS
Novartis
$1.85N/A-$1.85N/AN/AN/A
7/17/2024N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.73N/A-$2.73N/AN/AN/A  
7/16/2024N/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$6.70N/A-$6.70N/AN/AN/A  
5/8/2024Q1 2024
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
-$1.35-$1.43-$0.08-$1.43$25.53 million$0.50 million
5/6/2024Q1 2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$2.53$2.58+$0.05$2.68$8.94 billion$8.77 billion      
5/1/2024Q1 2024
CVS Health Co. stock logo
CVS
CVS Health
$1.69$1.31-$0.38$1.74$89.33 billion$88.44 billion      
5/1/2024Q1 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.56$0.82+$0.26$1.09$13.87 billion$14.88 billion    
4/25/2024Q1 2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$1.94$2.07+$0.13$2.27$15.21 billion$15.78 billion    
4/25/2024Q1 2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.47-$0.49-$0.02-$0.49$637.31 million$646.13 million    
4/23/2024Q1 2024
Novartis AG stock logo
NVS
Novartis
$1.73$1.80+$0.07$2.29$11.50 billion$11.83 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
N/AN/AN/AN/AN/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.08%+12.31%68.54%53 Years
CVS Health Co. stock logo
CVS
CVS Health
$2.664.33%+6.56%46.75%N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.963.33%+5.70%30.92%63 Years
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$5.200.59%+15.15%76.58%N/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.082.36%+6.08%342.22%13 Years
Novartis AG stock logo
NVS
Novartis
$2.432.31%+4.26%32.79%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.06%+2.57%N/A 15 Years
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$8.401.74%+14.71%51.34%15 Years

Latest Healthcare Stocks Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/14/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.552.13%7/15/20247/15/20248/15/2024
5/28/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.772.4%6/17/20246/17/20247/8/2024
6/5/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$2.101.7%6/17/20246/17/20246/25/2024
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/9/20245/10/20246/14/2024
5/6/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.300.69%5/15/20245/16/20246/10/2024
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
N/A
17.81
17.81
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.11
CVS Health Co. stock logo
CVS
CVS Health
0.78
0.81
0.61
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.36
1.17
0.94
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.90
1.35
1.03
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.77
1.25
0.99
Novartis AG stock logo
NVS
Novartis
0.43
0.90
0.71
Pfizer Inc. stock logo
PFE
Pfizer
0.66
1.05
0.78
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.67
3.82
3.74
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.69
0.85
0.85

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
47384.92 million81.44 millionOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.72 billionOptionable
CVS Health Co. stock logo
CVS
CVS Health
300,0001.26 billion1.25 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.40 billionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
43,000950.41 million949.17 millionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
72,0002.53 billion2.53 billionOptionable
Novartis AG stock logo
NVS
Novartis
76,0572.04 billion2.04 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.67 billion5.66 billionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,600169.59 million167.98 millionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
440,000920.39 million917.35 millionOptionable

Healthcare Stocks Headlines

Recent News About These Companies

UnitedHealth Group (NYSE:UNH) Shares Up 0%
UnitedHealth Group logo with Medical background
UnitedHealth Group (NYSE:UNH) Stock Price Down 0%
UnitedHealth Group (NYSE:UNH) Trading Down 1.7%
UnitedHealth Group (NYSE:UNH) Downgraded by StockNews.com to Hold

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

Company Descriptions

CRISPR Therapeutics logo

CRISPR Therapeutics

NASDAQ:CRSP
CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.
Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
CVS Health logo

CVS Health

NYSE:CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Eli Lilly and Company logo

Eli Lilly and Company

NYSE:LLY
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Merck & Co., Inc. logo

Merck & Co., Inc.

NYSE:MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Novartis logo

Novartis

NYSE:NVS
Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Teladoc Health logo

Teladoc Health

NYSE:TDOC
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
UnitedHealth Group logo

UnitedHealth Group

NYSE:UNH
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
Are you interested in trading healthcare stocks?

Investing in the healthcare sector may help your portfolio because almost everyone uses the healthcare system. Learn how to invest in healthcare.

Learn more about healthcare stocks